Real-time enrollment status for this waldenstrom's macroglobulinemia clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT04840602 |
| Recruiting Status | Suspended |
| Condition | Waldenstrom's Macroglobulinemia |
| Phase | Clinical Trial |
| Target Enrollment | 92 participants |
| Active Locations | 112 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 17, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT04840602 is currently suspended participants. This clinical trial study for waldenstrom's macroglobulinemia is not currently accepting new participants at 112 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04840602 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 112 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04840602 was last updated 1 week ago (February 17, 2026). HelloStudys verifies this status automatically.